宁波泰斯拓生物

www.testobio.com
  • 本公司产品仅供体外研究使用,不用于临床诊断
首页  /  产品中心  /  进口菌株

产品中心

试剂盒
菌株
质粒
试剂
联系我们  CONTACT US

0574-87917803

testobio@163.com

浙江省宁波市镇海区庄市街道兴庄路9号创e慧谷42号楼B幢401室
最新促销

货号: TS263591

名称: Candida metapsilosis


货号: TS263592

名称: Candida sake


货号: TS131909

名称: HFBCI28


货号: TS131910

名称: Septoria passiflorae Sydow, anamorph


货号: TS131911

名称: Graphium cuneiferum (Berkeley et Broome) Mason et Ellis


货号: TS131912

名称: Streptomyces scabiei (Thaxter) Lambert and Loria


货号: TSTOA0001

名称: Marisediminicola antarctica


货号: TS276951

名称: Real Time PCR EasyTM-Taqman


货号: TS276952

名称: Bacillus subtilis


货号: TS276954

名称: Bacillus subtilis

Vaccinia virus

货号 TS163073
中文名称 null
适应种属
检测范围
微信小陈 微信小章
在线留言
产品简介
购买须知
产品名称: Vaccinia virus
商品货号: TS163073
Classification: Poxviridae, Orthopoxvirus
Agent: Vaccinia virus
Strain: vP-53 strain VP53
Applications:
produces protein hemagglutinin, serotype H1
Biosafety Level: 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Isolation:
New York State Department of Health strain
Product Format: frozen
Storage Conditions: -70°C
Disclosure: This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Comments:
A recombinant of vaccinia (VTK-79), that contains an influenza HA gene.
This clone expresses the HA gene more strongly than either vP-9 (ATCC VR-2043) or vP-10 (ATCC VR-2044).
This clone expresses the hemagglutinin gene (serotype H1) of influenza virus and can be used in the production of antibodies against this protein.
A HindIII fragment coding for the influenza HA gene (blunted, BamHI linkers added) was cloned into the BamHI site of a PstI subfragment of the vaccinia HindIII F-fragment. This construct was cloned into VTK-79 (ATCC VR-2031) by in vivo recombination.
Effect on Host:
Cytopathic effects in tissue culture
Name of Depositor: E Paoletti
U.S. Patent:
U.S. Patent Number:
Source:
New York State Department of Health strain
References:

Paoletti E, Panicali D. Modified vaccinia virus. US Patent 4,603,112 dated Jul 29 1986

Paoletti E, Panicali D. Method for immunizing animals with synthetically modified vaccinia virus. US Patent 4,722,848 dated Feb 2 1988

Panicali D, et al. Two major DNA variants present in serially propagated stocks of the WR strain of vaccinia virus. J. Virol. 37: 1000-1010, 1981. PubMed: 6262520